300 related articles for article (PubMed ID: 29540770)
1. IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62.
Ball DH; Al-Riyami L; Harnett W; Harnett MM
Sci Rep; 2018 Mar; 8(1):4497. PubMed ID: 29540770
[TBL] [Abstract][Full Text] [Related]
2. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
3. Clock-dependent temporal regulation of IL-33/ST2-mediated mast cell response.
Kawauchi T; Ishimaru K; Nakamura Y; Nakano N; Hara M; Ogawa H; Okumura K; Shibata S; Nakao A
Allergol Int; 2017 Jul; 66(3):472-478. PubMed ID: 28259547
[TBL] [Abstract][Full Text] [Related]
4. ATP/IL-33-triggered hyperactivation of mast cells results in an amplified production of pro-inflammatory cytokines and eicosanoids.
Jordan PM; Andreas N; Groth M; Wegner P; Weber F; Jäger U; Küchler C; Werz O; Serfling E; Kamradt T; Dudeck A; Drube S
Immunology; 2021 Nov; 164(3):541-554. PubMed ID: 34142370
[TBL] [Abstract][Full Text] [Related]
5. The role of individual protein kinase C isoforms in mouse mast cell function and their targeting by the immunomodulatory parasitic worm product, ES-62.
Bell KS; Al-Riyami L; Lumb FE; Britton GJ; Poole AW; Williams CM; Braun U; Leitges M; Harnett MM; Harnett W
Immunol Lett; 2015 Nov; 168(1):31-40. PubMed ID: 26343793
[TBL] [Abstract][Full Text] [Related]
6. Pollen/TLR4 Innate Immunity Signaling Initiates IL-33/ST2/Th2 Pathways in Allergic Inflammation.
Li J; Zhang L; Chen X; Chen D; Hua X; Bian F; Deng R; Lu F; Li Z; Pflugfelder SC; Li DQ
Sci Rep; 2016 Oct; 6():36150. PubMed ID: 27796360
[TBL] [Abstract][Full Text] [Related]
7. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals.
Ho LH; Ohno T; Oboki K; Kajiwara N; Suto H; Iikura M; Okayama Y; Akira S; Saito H; Galli SJ; Nakae S
J Leukoc Biol; 2007 Dec; 82(6):1481-90. PubMed ID: 17881510
[TBL] [Abstract][Full Text] [Related]
8. Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation.
Abdala-Valencia H; Bryce PJ; Schleimer RP; Wechsler JB; Loffredo LF; Cook-Mills JM; Hsu CL; Berdnikovs S
J Immunol; 2015 Aug; 195(4):1377-87. PubMed ID: 26136426
[TBL] [Abstract][Full Text] [Related]
9. Kaempferol Suppresses the Activation of Mast Cells by Modulating the Expression of FcεRI and SHIP1.
Nagata K; Araumi S; Ando D; Ito N; Ando M; Ikeda Y; Takahashi M; Noguchi S; Yasuda Y; Nakano N; Ando T; Hara M; Yashiro T; Hachisu M; Nishiyama C
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983066
[TBL] [Abstract][Full Text] [Related]
10. A TLR2 ligand suppresses allergic inflammatory reactions by acting directly on mast cells.
Kasakura K; Takahashi K; Aizawa T; Hosono A; Kaminogawa S
Int Arch Allergy Immunol; 2009; 150(4):359-69. PubMed ID: 19571568
[TBL] [Abstract][Full Text] [Related]
11. Divergent Effects of Acute and Prolonged Interleukin 33 Exposure on Mast Cell IgE-Mediated Functions.
Rönnberg E; Ghaib A; Ceriol C; Enoksson M; Arock M; Säfholm J; Ekoff M; Nilsson G
Front Immunol; 2019; 10():1361. PubMed ID: 31275312
[No Abstract] [Full Text] [Related]
12. Lipopolysaccharide enhances FcεRI-mediated mast cell degranulation by increasing Ca2+ entry through store-operated Ca2+ channels: implications for lipopolysaccharide exacerbating allergic asthma.
Yang C; Mo X; Lv J; Liu X; Yuan M; Dong M; Li L; Luo X; Fan X; Jin Z; Liu Z; Liu J
Exp Physiol; 2012 Dec; 97(12):1315-27. PubMed ID: 22581748
[TBL] [Abstract][Full Text] [Related]
13. Stingray venom activates IL-33 producing cardiomyocytes, but not mast cell, to promote acute neutrophil-mediated injury.
Dos Santos JC; Grund LZ; Seibert CS; Marques EE; Soares AB; Quesniaux VF; Ryffel B; Lopes-Ferreira M; Lima C
Sci Rep; 2017 Aug; 7(1):7912. PubMed ID: 28801624
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Fc epsilon RI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes.
Melendez AJ; Harnett MM; Pushparaj PN; Wong WS; Tay HK; McSharry CP; Harnett W
Nat Med; 2007 Nov; 13(11):1375-81. PubMed ID: 17952092
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide/TLR4 Stimulates IL-13 Production through a MyD88-BLT2-Linked Cascade in Mast Cells, Potentially Contributing to the Allergic Response.
Lee AJ; Ro M; Cho KJ; Kim JH
J Immunol; 2017 Jul; 199(2):409-417. PubMed ID: 28600286
[TBL] [Abstract][Full Text] [Related]
16. Mutant Huntingtin affects toll-like receptor 4 intracellular trafficking and cytokine production in mast cells.
Pérez-Rodríguez MJ; Ibarra-Sánchez A; Román-Figueroa A; Pérez-Severiano F; González-Espinosa C
J Neuroinflammation; 2020 Mar; 17(1):95. PubMed ID: 32220257
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits IL-33-mediated mast cell activation by targeting the MK2/3-PI3K/Akt axis.
Nakajima S; Ishimaru K; Kobayashi A; Yu G; Nakamura Y; Oh-Oka K; Suzuki-Inoue K; Kono K; Nakao A
Sci Rep; 2019 Dec; 9(1):18423. PubMed ID: 31804564
[TBL] [Abstract][Full Text] [Related]
18. Epithelial cells expressed IL-33 to promote degranulation of mast cells through inhibition on ST2/PI3K/mTOR-mediated autophagy in allergic rhinitis.
Nian JB; Zeng M; Zheng J; Zeng LY; Fu Z; Huang QJ; Wei X
Cell Cycle; 2020 May; 19(10):1132-1142. PubMed ID: 32298206
[TBL] [Abstract][Full Text] [Related]
19. TLR2/MyD88-dependent and -independent activation of mast cell IgE responses by the skin commensal yeast Malassezia sympodialis.
Selander C; Engblom C; Nilsson G; Scheynius A; Andersson CL
J Immunol; 2009 Apr; 182(7):4208-16. PubMed ID: 19299719
[TBL] [Abstract][Full Text] [Related]
20. Blockage by SP600125 of Fcepsilon receptor-induced degranulation and cytokine gene expression in mast cells is mediated through inhibition of phosphatidylinositol 3-kinase signalling pathway.
Tanemura S; Momose H; Shimizu N; Kitagawa D; Seo J; Yamasaki T; Nakagawa K; Kajiho H; Penninger JM; Katada T; Nishina H
J Biochem; 2009 Mar; 145(3):345-54. PubMed ID: 19106158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
